Stories from Maastricht

22.12.2020 – 08:57

Proctorio
Coding problems at TestVision were the reason for the failures in online exams in The Netherlands

Munich (ots) - Students at Dutch universities had problems taking their exams online last week. The fault for this was not with Proctorio, as was claimed, but with TestVision. Last week, some students at Vrije Universiteit Amsterdam, Universiteit van Amsterdam, Maastricht University and Tilburg University had problems taking their exams online. The reason for this was ...

more
13.05.2020 – 15:45

Dpt of Precision Medicine, Maastricht University
The Department of Precision Medicine of Maastricht University Receives 920KEUR from the European Commission to Further Develop Their Work on Artificial Intelligence Tools for COVID-19 Patients

Maastricht, Netherlands (ots/PRNewswire) - The Department of Precision Medicine at Maastricht University(The Netherlands) announced today the release of their AI tool for COVID-19 patient triage, the same week that they received 920KEUR from the European Commission for the DRAGON project (link: information on the ...

more
21.03.2019 – 12:31

Deutsche Hospitality

2
Press Release: "Deutsche Hospitality increases its commitment in the Netherlands"
One document
more
30.07.2018 – 14:00

PSP Investments
PSP Investments Appoints Eduard van Gelderen as Chief Investment Officer

Montréal, Québec (ots/PRNewswire) - All $ are Canadian $ The Public Sector Pension Investment Board (PSP Investments) today announced the appointment of Eduard van Gelderen to the position of Senior Vice President and Chief Investment Officer. Mr. van Gelderen will lead PSP's Total Fund Strategy Group, overseeing multi-asset class investment strategies and total fund ...

more
30.04.2007 – 08:04

Astellas Pharma Europe Limited
Advagraf(R) Now Approved Across Europe as a Once-Daily Immunosuppressant in Organ Transplantation

London (ots/PRNewswire) - Astellas announced today that the European Commission has approved the immunosuppressant Advagraf(R) (generic name: tacrolimus, prolonged release) for prophylaxis of transplant rejection in adult kidney or liver allograft recipients and for the treatment of allograft rejection ...

more

1